Hengrui Medicine's GnRH receptor antagonist SHR7280 tablets was approved for clinical use
ZSP1273 Tablets, a subsidiary of Zhongsheng Pharmaceutical, received the US FDA Clinical Trial Approval Notice
On March 1, Zhongsheng Pharmaceutical issued a corporate announcement.
The announcement stated that recently
Tide Pharmaceutical's "Colesevelam Hydrochloride Tablets" was approved by the US ANDA
CSPC submitted desvenlafaxine succinate sustained-release tablet marketing applicant Fu has been approved for clinical use
Huahai Pharmaceutical's Metoprolol Succinate Sustained-Release Tablets and Silodosin Capsules were approved by the US FDA
Hengrui Medicine's Haitrombopag Ethanolamine Tablets Obtained the Qualification of US FDA Clinical Trial
Hutchison Medical's introduction of anti-tumor drug tazemetostat tablets for more than 300 million
Treat chronic hepatitis B! Zhengda Tianqing TQA3605 tablets were first approved for clinical use
Viterilon's first new drug, SIR1-365 tablets, was approved for clinical use in China
The use of levothyroxine sodium tablets in special populations
Tasly JS1-1-01 tablets were approved by the US FDA for clinical trials
Hengrui Medicine HRS2300 tablets were approved for clinical use
Pien Tze Huang's collaborative research and development project LDS tablets for the treatment of fibromyalgia was approved for clinical use
Yabao Pharmaceutical's first Sino-US dual-reported drug, sorafenib tablets, was approved for listing
Renfu Medicine: Metoprolol Succinate Sustained-Release Tablets Obtained US FDA Approval Number
Announcement of the State Food and Drug Administration on Revising the Instructions for Use
Can Pentovirine Citrate Tablets be Used to Treat Cough
Renfu Medicine HW021199 tablets are approved for clinical use in the treatment of idiopathic pulmonary fibrosis
What diseases can griseofulvin tablets be used to treat?
Can Hericium erinaceus tablets be used to treat gastrointestinal diseases?